Foresite Capital Management Iv, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Foresite Capital Management Iv, LLC

  • $149 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$15.08 - $26.0 $980,200 - $1.69 Million
-65,000 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$11.0 - $19.76 $715,000 - $1.28 Million
65,000 New
65,000 $1.01 Million
Q3 2019

Nov 13, 2019
SELL
$8.15 - $15.88 $520,964 - $1.02 Million
-63,922 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$16.25 - $28.09 $496,518 - $858,289
-30,555 Reduced 32.34%
63,922 $1.8 Million
Q2 2018

Aug 14, 2018
BUY
$16.73 - $20.35 $1.58 Million - $1.92 Million
94,477 New
94,477 $1.64 Million

Others Institutions Holding KNSA

# of Institutions
10
Shares Held
1.99M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $793M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email